Health Secretary Robert F. Kennedy Jr. said on May 14 that he’s ordered the Food and Drug Administration (FDA) to complete a review of the abortion pill mifepristone.
Sen. Josh Hawley (R-Mo.), during a hearing in Washington, highlighted an analysis of insurance claims that found 11 percent of women who took the drug experienced serious adverse events, a percentage far higher than the rate of under 0.5 percent in clinical trial participants.
“I think the new data … is alarming, and clearly it indicates that at the very least, the label should be changed,” Kennedy said.
The health secretary said he told Dr. Marty Makary, the FDA’s commissioner, to do a complete review of the data and report back….